How do you use cold agglutinin titers to guide your management of cold agglutinin disorders?

Is there a titer at which you recommend more aggressive approaches?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you approach ADT in patients with high-risk prostate cancer who have risk factors for VTE, such as Factor V Leiden?

Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?

How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.